Health Care: Drugs

Merck & Co Inc (MRK: NYSE)

$62.33 n/a | n/a%
04/28/17 - 04:00 PM ET
Company Income Statement
Dec 2016 Dec 2015 Dec 2014 Dec 2013
Sales 39.81B 39.50B 42.24B 44.03B
Cost of Sales 8.45B 8.56B 10.08B 9.97B
Gross Operating Profit 31.36B 30.94B 32.16B 34.07B
Selling, General, and Administrative Expenses 9.76B 10.31B 11.61B 11.91B
Research & Development 10.12B 6.70B 7.18B 7.50B
Operating Income before D & A (EBITDA) 11.47B 13.92B 13.37B 14.65B
Depreciation & Amortization 5.44B 6.38B 6.69B 6.99B
Interest Income 328.00M 289.00M 266.00M 264.00M
Other Income - Net -1.09B -1.97B 10.81B -278.00M
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) 5.35B 6.07B 18.02B 6.35B
Interest Expense 693.00M 672.00M 732.00M 801.00M
Pre-Tax Income 4.66B 5.40B 17.28B 5.54B
Income Taxes 718.00M 942.00M 5.35B 1.03B
Minority Interest 21.00M 17.00M 14.00M 113.00M
Net Income From Continuing Operations 3.94B 4.46B 11.93B 4.52B
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 3.94B 4.46B 11.93B 4.52B
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 3.92B 4.44B 11.92B 4.40B
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
3.94B 4.46B 11.93B 6.23B
Preferred Dividends
Net Income Available To Common 3.94B 4.46B 11.93B 4.52B
Basic EPS from Continuing Ops. 1.42 1.58 4.12 1.49
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 1.42 1.58 4.12 1.49
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 1.42 1.58 4.12 1.49
Basic Normalized Net Income/Share 1.42 1.58 4.12 2.05
EPS fr Continuing Ops. 1.41 1.56 4.07 1.47
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 1.41 1.56 4.07 1.47
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 1.41 1.56 4.07 1.47
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
1.41 1.56 4.07 2.03
Dividends Paid per Share 1.85 1.81 1.77 1.73

Portfolios with MRK

Latest MRK Headlines from TheStreet

More Financial News for MRK

Press Releases for MRK

See All Press Releases

Partner Headlines for MRK

brokerage partners
watch thestreet tv
No Videos Found
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter